BAY-1006451

N/A

Report date: 2025/12/01 17:16:45

Base Information

Drug NameBAY-1006451

Drug Alias Name[18F]-BAY-1006451BAY-1006451

ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionPositron-emission tomography enhancersMatrix metalloproteinase-2 bindersMatrix metalloproteinase 9 binders

TargetsMatrix metalloproteinase-2Matrix metalloproteinase 9

Therapy Area/IndicationsAtherosclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBayer HealthCare AG

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBayer HealthCare AG

Active IndicationsN/A

Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A